PDS Biotechnology Corporation

PDSB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014
Assets
Cash & Equivalents $88.1M $106.4M $130.2M $13.7M
Accounts Receivable — — — —
Inventory — — — —
Total Current Assets $89.1M $107.4M $131.3M $15.3M
Property, Plant & Equipment $3.4M $3.4M $2.8M $1.4M
Goodwill — — — —
Intangible Assets (Excl. Goodwill) — — — —
Total Assets $92.6M $110.9M $134.1M $16.8M
Liabilities
Accounts Payable $4.4M $3.5M $2.6M $2.0M
Total Current Liabilities $12.9M $6.7M $8.6M $3.9M
Long-Term Debt — — $5.5M —
Total Liabilities $93.2M $21.6M $11.6M $44.7M
Stockholders' Equity
Retained Earnings $-151.9M $-101.1M $-62.3M $-29.8M
Total Stockholders' Equity $-609.5K $89.3M $122.5M $-27.8M
← Newer Page 2 of 2 Older →